SBT-272 PEPTIDE 25MG VIAL

SBT-272 is a highly advanced, next-generation peptidomimetic engineered specifically for deep-tissue mitochondrial repair and profound neuroregeneration. As a novel cardiolipin-binding compound, its primary mechanism of action involves aggressively localizing to the inner mitochondrial membrane, where it forcefully stabilizes cardiolipin. This targeted structural reinforcement drastically improves mitochondrial morphology, restores optimal electron transport chain efficiency, and massive upregulates cellular ATP production while simultaneously quenching toxic reactive oxygen species (ROS). In elite-level neurological research, SBT-272 is heavily investigated for its exceptional ability to penetrate the blood-brain barrier, restore motor neuron function, mitigate severe ischemic damage, and actively repair the fundamental energy pathways in models of amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases.